title: Cost-effectiveness of glaucoma management with monotherapy medications in Egypt.
abstract: Glaucoma is a serious chronic ophthalmic disease since it causes irreversible visual disability if untreated can lead to blindness. Treatment options include medications (classified into five major classes of drugs which are muscarinic cholinergic agonists, alpha-2 adrenergic agonists, beta-1 adrenergic antagonists, prostaglandins [PGs], and carbonic anhydrase inhibitors); use of laser therapy or conventional surgery. Pharmacoeconomic analysis helps in choosing among this variety of treatments. There is a great need for such analysis in Egypt since undergoing of it in different countries or societies may produce different results. This work aimed to compare cost-effectiveness of bimatoprost 0.03% once daily versus brimonidine 0.2% twice daily and timolol 0.5% twice daily as monotherapy treatment in Egyptian patients with open-angle glaucoma or ocular hypertension. Clinical data revealed that all treatments decreased intraocular pressure (IOP) significantly but bimatoprost 0.03% showed the highest efficacy (27.7% decrease in IOP from baseline), while timolol 0.5% reduced IOP by 22.5% then brimonidine 0.2% which decreased IOP by 20.8%. From the cost-effectiveness view, it would be preferable to initiate treatment with timolol in case of absence of any contraindications. PG analog can be used as add-on therapy in low responder patients or as alternative treatment in case of presence of contraindication to use of beta blockers.
authors.affiliation: Lecturer, Military Medical Academy, Cairo, Egypt.
authors.forename: Amal Abd-Elaal
authors.initials: AA
authors.lastname: El-Khamery
authors.affiliation: Associate Professor, Military Medical Academy, Cairo, Egypt.
authors.forename: Amir Ibrahim
authors.initials: AI
authors.lastname: Mohamed
authors.affiliation: Department of Medical services, Consultant eye- surgeon FRCS Ed. Ophthalmology, Cairo, Egypt.
authors.forename: Hassan Eisa Hassan
authors.initials: HE
authors.lastname: Swify
authors.affiliation: Faculty of Pharmacy, Cairo University, Cairo, Egypt.
authors.forename: Alaa Ibrahim
authors.initials: AI
authors.lastname: Mohamed
keywords: Cost-effectiveness; glaucoma; pharmacoeconomic analysis